Adoptive immune cells for tumor vaccines

Details Adoptive immune cells for tumor vaccines Adoptive immune cells for tumor vaccines

2004-05-11

2010-02-02

Yu, Misook (Department: 1642)

Chemistry: molecular biology and microbiology

Maintaining blood or sperm in a physiologically active state...

Reexamination Certificate

active

07655393

ABSTRACT:
The present invention provides a method for preparing adoptive immune cells comprising the following steps of a) obtaining mammalian antigen-presenting associated cells; b) culturing the resulting cells in a culture vessel coated with a sugar chain-containing polymer; and c) detaching the cells by shaking the culture vessel without treating the cells with enzyme and without using a cell detaching tool; adoptive immune cells obtained by this preparing method; a culture vessel coated with a sugar chain-containing polymer for use in this preparation method; a kit for preparing an adoptive immune cell vaccine; and a method and a medicine for treating a malignant tumor, type I diabetes, atopic allergic diseases or infections using the adoptive immune cells.

REFERENCES:
patent: 5851756 (1998-12-01), Steinman et al.
patent: 6121044 (2000-09-01), Peshwa et al.
patent: 6642050 (2003-11-01), Goto et al.
patent: 2006/0177420 (2006-08-01), Felzmann
patent: 05-041983 (1993-02-01), None
patent: 08-317786 (1996-12-01), None
patent: 2001-520509 (2001-10-01), None
patent: 2002-69001 (2002-03-01), None
patent: WO 97/03186 (1997-01-01), None
patent: WO 97/05239 (1997-02-01), None
patent: WO 2004/024900 (2004-03-01), None
Hirose, et al, “Regulation of Asialoglycoprotein Receptor Expression in the Proliferative State of Hepatocytes,” Biochemical and Biophysical Research Communications, 287 (2001) 675-681.
Ishida, et al, “Cell Adhesion Aside from Integrin System Can Abrogate Anoikis in Rat Liver Cells by Down-regulation of FasL Expression, not by Activation of PI-3K/Akt and ERK Signaling Pathway,” Biochemical and Biophysical Research Communications, 300 (2003) 201-208.
Na, et al, “Conjugation of Arg-Gly-Asp (RGD) Sequence in Copolymer Bearing Sugar Moiety for Insulinoma Cell Line (MIN6) Culture,” Biosci. Biotechnol. Biochem, 65 (6), 1284-1289, (2001).
English-language International Preliminary Report on Patentability dated Nov. 14, 2006 and Written Opinion of the International Searching Authority, of International Application PCT/JP2004/006599 filed May 11, 2004; Applicants: Shukokai Incorporated et al.
D. Choi et al, “Dendritic Cell-based Vaccines in the Setting of Peripheral Blood Stem Cell Transplantation: . . . ”,Clin. Cancer Res., vol. 4, pp. 2709-2716, Nov. 1998.
F.J. Hsu et al, “Vaccination of patients with B-cell lymphoma . . . ”,Nat. Med., vol. 2, No. 1,pp. 52-58, Jan. 1996.
M. Takamizawa et al, “Cellular and Molecular Basis of Human γδ T Cell Activation”,J. Clin Invest., vol. 95, pp. 296-303, Jan. 1995.
V.L. Reichardt et al, “Idiotype Vaccination Using Dendritic Cells After Autologous Peripheral Stell Cell Transplantation for Multiple Myeloma . . . ”,Blood, Vo. 93, No. 7, pp. 2411-2419, Apr. 1999.
J. Wang et al, “Eliciting T Cell Immunity Against Poorly Immunogenic Tumors . . . ”,J. Immunol., vol. 161, pp. 5516-5524, 1998.
M.A. Morse et al, “A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide . . . ”,Clin. Cancer Res., vol. 5, pp. 1331-1338, Jun. 1999.
R.J. Hodes et al, “Cellular and genetic control of antibody responses in vitro”,Eur. J. Immunol., vol. 7, pp. 892-897, 1977.
Jos W.M Van Der Meer, “Culture of Mononuclear Phagocytes on a Teflon Surface to Prevent Adherence”,J. Exp. Med., vol. 147, pp. 271-276, 1978.
Jos W.M. Van Der Meer, “Suspension Cultures of Mononuclear Phagocytes in the Teflon Culture Bag”,Cell. Immunol., vol. 42, pp. 208-121, 1979.
R.M. Steinman et al, “Dendritic Cell Development and Maturation”,Adv. Exp. Med., pp. 1-6, 1997.

Affiliated with

Also associated with

Rating

Adoptive immune cells for tumor vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adoptive immune cells for tumor vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adoptive immune cells for tumor vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4233544